BIOTECH20 Videos

Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, today announced the achievement of the first major milestone in its collaboration with the College of Food, Agricultural, and Environmental Science of The Ohio State University. The primary program goal […]

Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, announced that its HUB platform of unique, ultra-high pressure instruments was featured in three presentations at the world’s largest annual food science conference, the Institute of Food […]

Pressure BioSciences, Inc. (OTCQB: PBIO) announced that the Company’s patented pressure cycling technology platform was prominently featured in 15 independent presentations at the annual conference of the American Society for Mass Spectrometry, held from June 1-6, 2019 in Atlanta, GA. The presentations spanned wide ranging applications for PBI’s unique PCT platform in scientific studies, particularly […]

Pressure BioSciences, Inc. (OTCQB: PBIO), today released a new, short video demonstrating the ability of the Company’s proprietary Ultra Shear Technology (UST™) platform to create water-soluble CBD oil that disperses instantly, resulting in improved dosing effectiveness, enhanced absorption, and more aesthetically-pleasing products when added to carbonated soft drinks, vitamin-infused sports drinks, and beer. Pressure BioSciences, […]

Pressure BioSciences, Inc. (OTCQB: PBIO) announced the establishment of a Center of Excellence at Dr. Christine Vogel’s laboratory at New York University’s Center for Genomics and Systems Biology. Pressure BioSciences, Inc. is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based […]

The Children’s Tumor Foundation (CTF) is a foundation dedicated to improving the health and well-being of individuals and families affected by neurofibromatosis (NF). The Foundation is the largest private funder of NF research and works to create the best forms of treatment for sufferers of NF. Annette Bakker, the Children’s Tumor Foundation’s President and Chief […]

Biome Grow Inc. (OTCQB: BIOIF) (CSE: BIO) announced that Mr. George Smitherman has joined Biome Grow’s executive management as Senior Vice President of Corporate Affairs. In this role, George will be leveraging his experience and knowledge in the Canadian health care sector to accelerate Biome’s growth in new operating verticals. His portfolio of responsibilities will […]

Based in Houston, Texas, SpinalCyte, LLC, is a regenerative medicine company developing an innovative solution for spinal replacement using human dermal fibroblasts. Currently, SpinalCyte holds 39 U.S. and international issued patents and has filed for an additional 100+ patents pending and issued across a variety of clinical pathways, including disc degeneration, cancer, diabetes, liver failure […]

Pressure BioSciences, Inc. (OTCQB: PBIO) a leader in the development and sale of pressure-based instruments and platform technologies to the life sciences and other industries worldwide, today announced a collaboration with The Steinbeis Centre for Biopolymer Analysis & Biomedical Mass Spectrometry, a world-renown German research organization. Pressure BioSciences, Inc. is pressure-based platform solutions for the […]

Q BioMed Inc. (OTCQB: QBIO) aims to accelerate the monetization of biomedical technologies through rapid innovation and collaborative partnerships with industry-leading researchers. Q BioMed believes its assets in oncology, vascular disease, and rare orphan diseases address unmet medical needs and large markets. Mr. Denis D. Corin is Chief Executive Officer and Chairman of the Board. […]